Green Thumb Industries Inc
CNSX:GTII
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
G
|
Green Thumb Industries Inc
CNSX:GTII
|
2B CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
923.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
582.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
253.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.8B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.7B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Green Thumb Industries Inc
Glance View
Green Thumb Industries Inc., a notable player in the U.S. cannabis industry, operates like a well-tuned orchestra, harmonizing various elements of the cannabis business. The Chicago-based company is vertically integrated, meaning it controls each aspect of its product lifecycle—from cultivation to distribution. This structure enables Green Thumb to maintain consistency in its product quality while maximizing its operational efficiency. At the heart of its business model lies a diverse portfolio of well-regarded cannabis brands that cater to different consumer segments, from high-end connoisseurs to medicinal users seeking relief. These brands, including RYTHM, Dogwalkers, and Beboe, are strategically distributed across its extensive network of retail outlets, known as RISE dispensaries, as well as through wholesale channels. Like a savvy trader on a bustling market floor, Green Thumb’s profitability hinges on its ability to enhance scale while navigating the complex regulatory landscape. In each state where it operates, the company must tailor its approach to meet varying levels of regulation and market maturity. This agility provides Green Thumb with a competitive edge, allowing it to efficiently expand in both medical and adult-use markets while adhering to legal standards. The company generates revenue not only from its direct-to-consumer sales through dispensaries but also through wholesale transactions with other cannabis retailers. By maintaining robust relationships across these segments, Green Thumb underscores its position as a cornerstone of the cannabis industry's growth narrative.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Green Thumb Industries Inc is 9.7%, which is above its 3-year median of 3.6%.
Over the last 3 years, Green Thumb Industries Inc’s Net Margin has increased from 1.2% to 9.7%. During this period, it reached a low of -1.8% on Jun 30, 2023 and a high of 9.7% on Jan 1, 2026.